R. RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiol Genomics 45: 287-299, 2013. First published February 5, 2013 doi:10.1152/physiolgenomics.00001.2013.-We performed high throughput transcriptomic profiling with RNA sequencing (RNA-Seq) to uncover network responses in human THP-1 monocytes treated with high glucose (HG). Our data analyses revealed that interferon (IFN) signaling, pattern recognition receptors, and activated interferon regulatory factors (IRFs) were enriched among the HGupregulated genes. Motif analysis identified an HG-responsive IRFmediated network in which interferon-stimulated genes (ISGs) were enriched. Notably, this network showed strong overlap with a recently discovered IRF7-driven network relevant to Type 1 diabetes. We next examined if the HG-regulated genes possessed any characteristic chromatin features in the basal state by profiling 15 active and repressive chromatin marks under normal glucose conditions using chromatin immunoprecipitation linked to promoter microarrays. Composite profiles revealed higher histone H3 lysine-9-acetylation levels around the promoters of HG-upregulated genes compared with all RefSeq promoters. Interestingly, within the HG-upregulated genes, active chromatin marks were enriched not only at high CpG content promoters, but surprisingly also at low CpG content promoters. Similar results were obtained with peripheral blood monocytes exposed to HG. These new results reveal a novel mechanism by which HG can exercise IFN-␣-like effects in monocytes by upregulating a set of ISGs poised for activation with multiple chromatin marks. high glucose; monocytes; diabetic complications; interferon regulatory factors; chromatin state CHRONIC HYPERGLYCEMIA OR GLUCOSE toxicity associated with both Type 1 (T1D) and Type 2 diabetes has been attributed to the development of various complications including cardiovascular disease, neuropathy, nephropathy, and retinopathy (7, 8, 17, 48) . These complications can result from the adverse effects of high glucose (HG) on many fundamental biological processes in target tissues and cells. As the soaring rates of diabetes and its complications have become major health care issues, it is imperative to examine the underlying mechanisms by evaluating signaling molecules, networks, genetic, and epigenetic elements that contribute to the relevant deregulated pathways using emerging new technologies.
CHRONIC HYPERGLYCEMIA OR GLUCOSE toxicity associated with both Type 1 (T1D) and Type 2 diabetes has been attributed to the development of various complications including cardiovascular disease, neuropathy, nephropathy, and retinopathy (7, 8, 17, 48) . These complications can result from the adverse effects of high glucose (HG) on many fundamental biological processes in target tissues and cells. As the soaring rates of diabetes and its complications have become major health care issues, it is imperative to examine the underlying mechanisms by evaluating signaling molecules, networks, genetic, and epigenetic elements that contribute to the relevant deregulated pathways using emerging new technologies.
Several biochemical mechanisms have been implicated in hyperglycemia-induced cellular damage (7, 8) , including increased oxidant stress, activation of protein kinase C and other signaling kinases, as well as formation of advanced glycation end products. Evidence also shows that the expression of inflammatory cytokines and chemokines, Toll-like receptors, and many signaling molecules are affected by HG in primary human monocytes and THP-1 monocytes (5, 10, 11, 13, 20, 24, 32, (45) (46) (47) 53) and that this leads to the impairment of key biological pathways. Despite these efforts, our understanding of the genome-wide effects of HG in target cells remains incomplete, largely because majority of these studies were based on the evaluation of candidate genes, which therefore leaves a vast number of genes unexplored.
In recent years, high-throughput technologies such as RNA sequencing (RNA-Seq), chromatin immunoprecipitation linked to microarrays (ChIP-chip), ChIP-Sequencing (ChIP-seq), and bioinformatics analysis tools have yielded unprecedented insights into the transcriptome and epigenome and significantly enhanced biomedical research (21, 39) . RNA-Seq can identify all transcripts in a cell in an unbiased manner, including novel protein coding and noncoding genes previously missed by traditional microarray expression profiling. It has emerged as a powerful tool to uncover previously unknown details of transcriptome changes under disease conditions (30, 51) . In addition, ChIP-chip or ChIP-Seq and other related tools allow us to map histone posttranslational modifications (PTMs), DNA methylation, and the other components of the epigenome, as well as regulatory elements on a genome-wide scale (16, 42, 54) . Because of the fundamental importance of HG to diabetes and diabetes complications, it is worthwhile to examine the genome-wide effects of HG in the context of these new technologies. By profiling key epigenetic histone PTM marks in HG-treated human monocytes using ChIP-chips, we previously identified genes and chromatin regions in which histone methylation levels were altered by chronic HG as well as their correlation with gene expression (34) . Using the same ChIPchip technology in peripheral blood monocytes and lymphocytes obtained from T1D patients and healthy controls, we also found genomic regions that had differential levels of several histones PTMs (31, 33) . Another study using next-generation sequencing reported genome-wide changes in DNA methylation and histone H3 lysine 9/14 acetylation (H3K9/K14Ac) in HG-treated human endothelial cells, which revealed several known and novel genes and pathways associated with endothelial dysfunction (38) .
In this study, we used RNA-Seq to investigate changes in the transcriptome in response to HG in human THP1 monocytes. Data analyses revealed key previously unidentified genes, transcription factors (TFs), and networks among the HG-upregulated transcripts. In addition, by profiling 15 selected histone PTM marks using ChIP-promoter arrays, we explored the chromatin features at the promoters of HG-upregulated genes in the basal unstimulated state. Key validations were also performed in primary human blood monocytes treated with HG. Overall, these approaches have uncovered new genome regions targeted by HG, as well as their related chromatin states in cells related to diabetic complications, which could lead to the identification of much-needed new therapeutic targets for subjects with debilitating complications of diabetes.
MATERIALS AND METHODS
THP-1 cell culture and human blood monocytes. THP-1 cells (from ATCC) were cultured in RPMI 1640 medium containing normal glucose (NG, 5.5 mM) or HG (25 mM) and 10% serum for 72 h. Endotoxin levels were monitored with the Limulus Amebocyte Lysate QCL-1000 kit (#50-647U, Lonza). Peripheral blood mononuclear cells were isolated from healthy donors using endotoxin-free FicollPaque Plus (GE Healthcare 17-1440-03) according to an approved Institutional Review Board protocol. Monocyte CD14 ϩ cells were purified with enrichment kits (STEMCELL Technologies cat. no. 19059).
mRNA preparation for RNA-Seq. Total RNA and polyA RNA were prepared by standard protocols. PolyA RNA was depleted of rRNA with RiboMinus kits (Invitrogen), and then RNA-Seq was performed after library preparation in our Sequencing Core according to the Illumina protocols.
Real-time quantitative PCR. RT-QPCR (QPCR) for quantifying gene expression were performed with cDNA prepared from THP1 cell and human monocyte total RNAs. The following PCR primers were used: STAT2 (5=-CTTTGTGAGTCGGAGCCAGGAG-3= and 5=-CTACTCTTGTACG-GTTGCACAGAGTAG-3=), STAT1 (5=-CGAATACTTTCC CTGA CAT-CATTCG-3= and 5=-TCCTTTAGGGCCATCAAGTTCC-3=), ISG15 (5=-GCGAACTCATCTTTGCCAGT-3= and 5=-AGCATCTTCACCGT-CAGGTC-3=), IFIT3 (5=-GCAGAGACACAGAGGGCAGT-3= and (28) . For RNA-Seq, the sequences were processed and normalized with reads per kb per million (RPKM) as described in MATERIALS AND METHODS. The RPKM expression level of each transcript was log2 transformed with offset 1. For Affymetrix data, raw intensity measurements were processed by RMA. The expression level of each transcript cluster across 3 replicates was then averaged. For a transcript represented by multiple transcript clusters, its expression level was the average level of all these clusters. A total of 18,029 common RefSeq transcripts shared by both platforms were plotted. Each dot represents the expression levels of 1 transcript, with data from Affymetrix arrays represented on the y-axis and RNA-Seq data on the x-axis. Pearson's correlation coefficient (R) between the 2 platforms is also shown. (21,298 total) were summarized, RPKM-normalized, and transformed into log2 (reads #ϩ1) format. Each point represents the expression level of 1 gene in NG and HG culture conditions. Differentially expressed genes were identified by the following criteria: 1) minimum RPKM normalized reads Ն 10 in either cell culture condition; 2) fold change Ն 2. The triangles represent 337 genes that were upregulated in HG, while squares represent the 326 genes that were downregulated in HG. The remaining dots represent genes that were not differentially expressed as per these described criteria. B: Ingenuity Pathway Analysis report of HG-upregulated and downregulated genes with enrichments of P Ͻ 1ϫ 10 Ϫ4 . ABHD4  CCDC88B  FURIN  JUNB  OASL  RHOC  TIMP3  ACCN2  CD300A  FYN  KCNE1  OBSL1  RNF213  TKTL1  ACSL1  CD82  G0S2  KCNG1  OGFR  RNF24  TLE3  ADAMTS2  CDC42EP1  GAB2  KCNK5  OGT  RNF41  TMCO4  ADAP1  CDC42EP3  GAS7  KIAA1618  ORM1  RNPEPL1  TMEM63A  ADAR  CDKN1A  GDF15  KIAA1958  ORM2  ROGDI  TNF  ADM2  CEACAM19  GIPC1  KIF21B  P2RX4  RPS19BP1  TNFRSF10B  ADRB1  CEBPB  GPR132  KIFC3  P2RY11  RPS6KA2  TNFRSF1B  AGRN  CHAC1  GPT2  KLF10  PACSIN2  S100P  TOX2  AHNAK  CHD2  GRB10  KLHL13  PAG1  SAMD9L  TRIB3  AKNA  CHPF  GTPBP2  LAT  PARP10  SDC2  TRIM22  ALDH1L2  CKAP4  H1F0  LBH  PARP12  SDC3  TRIM56  ALOX5  CLTB  HAX1  LGALS3BP  PARP14  SEMA4C  TRIM8  ALOX5AP  CMPK2  HBEGF  LIMD1  PARP9  SERPINE2  TSC22D3  ANGPTL6  CORO1A  HDAC5  LIMD2  PCBP4  SESN2  TSC22D4  ANKRD11  COX19  HERPUD1  LMNA  PCK2  SH3BP1  TSSC4  AP2A2  CREBBP  HES6  LOC153684  PCNX  SH3BP2  TTYH3  APBA2  CSF3R  HLA-A  LOC728855  PDLIM7  SH3GL1  TWF2  APOL6  CST7  HLA-E  LOC728875  PDZD7  SHISA5  TXNIP  ARAP1  CTSD  HLA-F  LOC90246  PEA15  SHMT2  TYMP  ARHGEF10L  CXXC5  HLA-H  LONP1  PEX6  SIGLEC1  UBA7  ARRDC4  DBN1  HMBOX1  LRP10  PGAM2  SLC12A8  UBE2L6  ASNS  DDAH2  HMHA1  LRRC3B  PHC2  SLC16A3  UBXN6  ASS1  DDIT4  HOMER3  LY6E  PHGDH  SLC1A5  UHMK1  ATF5  DNM1  HPCAL1  MALAT1  PKD1  SLC27A3  USP18  ATG4D  DRAM1  HSH2D  MAP1B  PLEC1  SLC31A1  VEGFA  AXL  DTX3L  HSPB7  METRNL  PLEK  SLC37A2  WARS  BARX1  EEF1A2  IER2  MFAP4  PLSCR1  SLC3A2  WDR45  BATF3  EHBP1L1  IFI27  MGC12982  PLXNA1  SLC43A1  XAF1  BCL2L11  EIF2AK2  IFI35  MICAL2  PPAN-P2RY11  SLC6A9  ZBTB7B  BEST1  EIF2C2  IFI44  MID1IP1  PPARD  SLC7A5  ZFAND3  BRPF3  EIF4EBP1  IFI44L  MKNK2  PPM1M  SMG5  ZFP36L1  C10orf54  EPSTI1  IFI6  MLST8  PPP1R3C  SNTB1  ZNF513  C12orf44  ESRP1  IFIH1  MMP14  PRPSAP1  SP110  ZNF516  C14orf49  ESRRA  IFIT1  MOV10  PSAT1  SPNS3  ZNF740  C16orf79  ETS1  IFIT2  MRC2  PSTPIP1  SPSB3  ZNFX1  C19orf22  F11R  IFIT3  MX1  PTP4A3  SQSTM1  ZXDC  C19orf66  FAM125A  IFITM1  MX2  PUS1  SSBP2  C1orf84  FAM134B  IFITM3  MYH9  PVR  ST3GAL1  C1RL  FAM84B  INHBE  MYO15B  PYCR1  ST6GALNAC3  C3AR1  FBXO6  IRF1  NCAM1  QSOX2  STAT2  C3orf54  FCER2  IRF7  NFE2L1  RAB3D  STC2  C5AR1  FEZ1  IRF9  NFIL3  RARA  STK10  C9orf37  FGD3  ISG15  NFKBIL1  RBCK1  SYTL1  C9orf89  FGR  ITGAL  NINJ1  RCAN1  TAP1  C9orf91  FLJ35024  ITGB2  NR1H2  REC8  TBX15  CAMTA2  FLJ39739  ITGB7  NUPR1  RELL2  TESC  CAP2  FLNA  ITPRIP  OAS1  RFXANK  TFEB  CBX4  FLRT1  JDP2  OAS2  RGMA  THTPA  CCDC69  FOSL2  JUB  OAS3  RGS16  TIMM44 HG, high glucose.
RNA-Seq data analysis. Raw sequences were aligned to the human hg18 genome assembly using Bowtie. The aligned reads were imported to Partek Genomic Suite (version 6.5 beta; Partek, St. Louis, MO) to obtain the expression level for each RefSeq transcript by summarizing the number of reads located within each gene's exon(s). Expression data at the single gene level were calculated by combining the reads within all transcripts of the same gene. Fisher's exact test was applied to gene level expression data to compare HG and NG conditions, and the resulting P values were adjusted by the Bonferroni method. Gene level expression data were further normalized to obtain reads per kb per millions of aligned reads (RPKM) and the fold changes between HG and NG calculated based on RPKM data. For a gene with more than one transcript, gene length was defined as the length of the longest transcript. Differentially expressed genes between HG and NG were identified by the following criteria: 1) RPKM Ն10 in either one cell culture condition and 2) fold change between the samples Ն2.
Motif analysis. The promoter regions [Ϫ500 bp to 100 bp relative to the transcription start site (TSS)] of the HG-upregulated genes identified by RNA-Seq in this study were examined for the enrichment of TF binding motifs, defined in the Transfac's nonredundant vertebrate database using Biobase TF Explain analysis system (version 2.4.2). The background gene set was defined as the 1,000 most commonly expressed genes under HG and NG conditions that have the largest P values and whose RPKM Ն10 in at least one sample. The motifs that are enriched in HG-upregulated genes were identified with Biobase's MATCH function. The motifs with P Յ 1ϫ10 Ϫ5 and an enrichment fold, defined as average number of matched motifs per promoter in HG-upregulated genes versus that in background genes, of no less than 1.25 were considered enriched in HG-upregulated genes.
Promoter CpG-content based gene classification. HG-upregulated genes were classified into groups consisting of those with of high CpG content promoters (HCP), intermediate CpG content promoters (ICP), and low CpG content promoters (LCP) based on the promoter CpG Table 2 .
HG-downregulated gene list (326) by RNA-Seq in THP1 cells
Gene Name
Gene Name Gene Name Gene Name Gene Name Gene Name Gene Name HSD11B1  UBE2T  DUT  PRDX6  CDCA3  METTL7B  SNRPG  HLA-DRA  KPNA2  PAQR8  RNASE2  FAM83D  C15orf57  PCYOX1L  BNIP3  GLA  BUB1B  NUDT7  NDUFS5  RPS23  RPL22  SERPINB2  ARL6IP1  HSP90B1  RBBP7  MANF  PARP1  ATP6V1C2  DEFB1  AIG1  PRR11  PRIM1  GINS1  RPS24  PSMG2  MS4A6A  IGFBP7  NUTF2  NP  SFRS2  C11orf1  CKAP2  SERPINB10  RRM1  TMEM106C  C4orf46  HSP90B3P  CCNB2  PPIAL4B  CEACAM6  SLC25A5  ROMO1  CAPNS1  CCDC99  UQCRH  LTA4H  GPR160  CCNA2  GPI  PLK1  CACNA2D3  MRPS28  BLM  ALDOC  C10orf75  CACYBP  OAT  ANXA4  COX6C  NEIL3  S100A8  CCNE2  DHCR7  CAT  RPS17  RAN  STRA13  HSPE1  CENPF  RPL7A  TUBA1A  HPRT1  RAB11A  IPO5  NDUFB6  UBE2C  NUSAP1  CEP55  RPSAP58  RPL39L  ENOSF1  CD302  KIF11  RPS25  RPS3A  HAUS1  RPLP2  ADSS  GLO1  PTTG3P  PAICS  GPC3  CCNG1  C11orf82  C9orf100  GAL  HMGB1L1  ZWINT  RFC3  C14orf19  TPI1  SRI  HMMR  EBPL  TRIP13  RPL39  HSP90AB1  C13orf27  PRC1  MS4A3  SC4MOL  EIF3E  MS4A7  RANBP1  C6orf129  FEN1  KIF20A  PCNA  RPL5  RPS4X  RPL23P8  EAF2  RNASE3  ACOT7  TUBA1B  FDFT1  PENK  NMNAT3  NDUFAB1  GNL3  PTTG1  CCL23  NXT2  COX6B1  THOC4  INSIG1  RPL26  HMGCS1  RNPEP  HMGCR  ECT2  NME2  NUP37  GTF3C6  FABP5  SERPINB8  SNRNP25  BEX1  GNG10  RPS7  DDT  CALR  B3GNT7  KIF23  HISPPD1  HIBADH  CETN3  NCAPH  TFRC  BUB1  PLK4  C20orf103  CYB5A  PPIAL4A  NGFRAP1  PRTN3  TUBA1C  MND1  HNRPA1L-2  HNRNPA1  APOBEC3B  C14orf147  ACAT2  C8orf45  NEK2  NUF2  FH  NTAN1  GCSH  TYMS  TTK  CETN2  KHDRBS1  PPIAL4C  SNHG6  FBXO5  CSTB  RPS15A  MTCH2  CALM2  NPC2  TECR  C16orf73  C18orf10  DHFR  RPS14  KIAA0101  AKR1B1  WBP5  CBX1  RPL23AP64  PBK  NUCB2  SKP2  THBS4  NCAPG  GATM  CERKL  CDKN3  RPL21  RPL14  RPL30  RPL23A  THOC3  LDHA  TXN  HSPD1  NDUFA1  SLC25A3  C7orf30  DLGAP5  RPL21P28  PKIB  UCP2  PPA1  SYNC  MT1G  HMGB1  RPL7  RPA3  HNRNPR  HSP90AB2P  CCNB1  ACAT1  DEPDC1B  MLF1IP  HLA-DQB1  MCM3  C6orf173  CXCR4  HEXB  HMGB2  DNAJC25-GNG10  TBCA  HINT1  NME1  NDUFA12  GBE1  RPSA  CENPH  DCK  RPL11  LYZ  SKP1  PSRC1  MRPL36  MAD2L1  EEF1B2  SF3A3  NDUFA4  GSTM3  HJURP  MNDA  TMEM97  KYNU  C2orf79  RPL9  GPNMB  STMN1  NDUFB8  SNRPE  C1orf54  CNN3  AURKA  GAMT  PPA2  RPS26P11  ATP5G3  PIR  EIF3L  ASPM  CDC20  MYEOV2  ANLN  DNAJC5B  EPR1  CDCA7  CDC2  IDI1  TPX2  P4HA1  NPM1  PRDX1  GGH  NDC80  RRM2  E2F8  S100A10  TOP2A  RPL23  EEF1G  NDUFA7  LOC728554  EIF2A  TUBB  ARPC5  HSP90AA1  AP1S3  SNRPF  C10orf58  DARS2  SOD1  FAM166A  NME1-NME2  CENPA  WDR54   290 HIGH GLUCOSE-INDUCED TRANSCRIPTOME AND EPIGENETIC PROFILES http://physiolgenomics.physiology.org/ content (Ϫ500 bp to 500 bp relative to TSS). The sequence of each gene's promoter based on the hg18 genome assembly was scanned using a sliding window of 500 bp in length with a 5 bp step. HCPs were defined as promoters containing at least one 500 bp region with CpG ratio Ͼ0.75 and GC content Ͼ55%, while LCPs were defined as promoters without a 500-bp region of CpG ratio Ͼ0.48. ICPs were those not classified into either HCP or LCP (52) . For convenience, the HCP and ICP were combined as HCP/ICP in this study.
ChIP-chip data heat map and composite profile generation. For ChIP-chip data analyses, the promoter regions of each transcript in gene sets (presented in Figs. 4 and 5) were divided into nonoverlapping 100 bp windows, each as a positional bin. For each chromatin mark, log2 enrichment ratios of the microarray probes falling into each transcript's promoter region were retrieved, aligned, and assigned to the positional bin, which resulted in a data matrix containing the PTM level of a specific chromatin mark with each row representing one RefSeq transcript's promoter and each column representing each bin. Then the rows of the matrix were ordered by the expression levels of their corresponding genes [either measured by Affymetrix expression data from our earlier study (28) or RNA-Seq expression data (from the current study); see the figure legends for more details] and visualized by Java TreeView v1.1.3 to generate the heat map. For each gene set, averages of the data in each column were then calculated and plotted to generate composite profiles as also described earlier (31).
Calculation of gene-level H3K4me3 enrichment at defined promoter region. For specific candidate genes of interest, the average H3K4me3 level at its defined promoter region was calculated using all the probes located in the region of the corresponding gene. For genes with more than one isoform, the H3K4me3 level was the average level of all its isoforms.
Data deposition. The data reported in this study is deposited in the NCBI Gene Expression Omnibus database (GSE43871).
RESULTS

RNA-Seq analysis of gene expression in THP-1 cells under HG conditions.
We mimicked diabetic conditions by culturing THP-1 monocytes in HG (25 mM) relative to NG (5.5 mM) for 72 h (half-life of human monocytes). mRNA isolation and RNA-Seq were performed as described under MATERIALS AND METHODS. We first compared the RNA-Seq data of THP-1 cells grown in NG to the gene expression dataset obtained previously using Affymetrix microarrays (28) and observed close correlations between these two approaches (Pearson's r ϭ 0.75, Fig. 1 ), consistent with published results (Spearman's rho ϭ 0.73-0.75) (29) . For the RNA-Seq data, using the criteria of minimum RPKM normalized value Ն 10 in either sample and fold change Ն2, a total of 337 HG-upregulated genes and 326 HG-downregulated genes were selected (Fig. 2A) . The full gene list is provided in Table 1 and Table 2 . Ingenuity Pathway Analysis (Ingenuity Systems, http://www.IPA.com) showed that interferon (IFN) signaling, virus entry pathway, cytosolic pattern recognition receptors, activated interferon regulatory factors (IRFs) and the ERK/MAPK signaling pathways were among the top canonical pathways enriched (P Ͻ 1ϫ10 Ϫ4 ) in the HG-upregulated genes (Fig. 2B ). This suggested a strong connection between HG effects and IFN-related pathways. Within the downregulated genes, enriched pathways included mitotic cell cycle, protein complex assembly, DNA metabolic process, DNA repair, ribosome biogenesis, rRNA processing, oxidative phosphorylation, and mitochondrial electron transport (Fig. 2B) .
Promoter motif analysis indicates that IRFs participate in HG-upregulated gene expression in THP1 cells. Gene networks triggered by dysregulated TFs can significantly amplify signals that drive cells into abnormal states. Earlier studies have shown that increased activity of NF-B TF is associated with HG effects in monocytes (10, 11, 20, 32, 46) . In our current RNA-Seq data, we also observed the induction of several known NF-B target genes including TNF␣ and CCL2 (data not shown). To further identify specific TFs that regulate genes upregulated by HG in THP-1 cells, we performed a motif analysis of the 337 upregulated genes (Table 1) for TF binding sites using Biobase Explain software. Results showed that IRF motifs were significantly enriched in the promoter regions of HG-upregulated genes identified in this study (Table 3) . Notably, this unbiased in silico analysis indicated for the first time that IRFs and their target genes are the most highly enriched gene sets induced by HG, indicating the power of RNA-Seq to uncover previously underestimated transcripts, TF regulated pathways and related factors affected by HG.
We next assessed whether specific IRFs were differentially expressed in response to HG by RNA-Seq and found that IRF1, Each motif represents the corresponding transcription factor(s) listed in the "Gene" column. Enrichment ratio for each matrix represents the ratio of the average number of matched motif binding sites per 1,000 bp in the promoters of HG-upregulated genes vs. background genes (see MATERIALS AND METHODS for background gene set selection). "TF Matrix"column shows the names of Transfac Position Weight Matrices (PWM) motifs. Significance of the representation is measured by the P value derived from binomial distribution. Motifs with P Ͻ 1ϫ10 Ϫ5 and enrichment ratio Ͼ1.25 are listed. The motifs in boldface (in the top 3 rows) are considered as highly enriched with P Ͻ 1E-12 and enrichment ratio Ͼ 3. Transcription factors corresponding to the 3 highly enriched motifs (P Ͻ 1E-12 and enrichment fold Ͼ 3) are listed. The gene-level expression in THP1 grown under normal glucose (NG) and HG levels were measured by RNA-Seq with reads per kb per million (RPKM) normalization. Genes with RPKM normalized reads Ն1 in THP1 cells grown in either 1 condition and expression level fold change between HG vs. NG no less than1.5 are considered differentially expressed. IRF, interferon regulatory factor. IRF2, IRF7, and IRF9 were all highly upregulated (Table 4) . To further identify specific target genes and networks regulated by IRFs, we scanned the promoter regions of the 337 HGupregulated genes (Ϫ500 bp to 100 bp relative to TSS) ( Table  1) to detect those containing at least one binding site of the IRF-related matrices. As a result, 81 potential IRF target genes were identified among the HG-upregulated genes that we designated as high glucose-induced IRF network (HGIN) (81 gene list provided in Supplementary Table S1 in Supplementary Materials).
1 Notably, this HGIN was highly enriched in typical antiviral response interferon-stimulated genes (ISGs) driven by IRFs. To verify the RNA-Seq data, we selected key HGIN genes (ISG15, STAT2, IFI27, IFI44, IFIT3, IRF7, OAS2, and ALOX5), STAT1 as well as positive controls TNF-␣ and IL-1␤ for further validation by RT-QPCR using separate RNA obtained from THP-1 cells treated with HG or osmotic control (19.5 mM mannitol ϩ NG). Results showed that all these genes, except STAT2 and the negative control PCNA, were upregulated by HG, but not by mannitol (Fig. 3) . Importantly, we also verified that the culture medium had no detectable LPS/endotoxin contamination.
A recent integrated study of datasets from genome-wide gene expression and sequence variations in rat tissues identified an IRF7-driven inflammatory network (IDIN) that was also enriched in human monocytes and was shown to contribute to T1D risk (22) . Both this reported IDIN and our current HGIN gene networks are regulated by IRF, and we found a significant overlap between them ( 2 P Ͻ 2.2 ϫ 10 Ϫ16 ).
Twenty-eight out of our 81 HGIN genes (Supplementary Table  S1 ) were also present in IDIN (Table 5) , suggesting a strong internal correlation between the two networks. A closer examination of these 28 genes revealed that this correlation was primarily represented by the type 1 IFN response since the signature molecules of ISGs such as ISG15, OASL, MOV10, IFI44L, IFITM3, MX1, and EIF2AK2 were included (44) . Interestingly, there were no detectable reads for IFN-␣ in the RNA-Seq data, while IFN-␤ reads were slightly increased by 1 The online version of this article contains supplemental material. Twenty-eight genes shared in both high glucose-induced IRF network (HGIN) and IRF7-driven inflammatory network (IDIN) were obtained by comparing our HGIN with the published IDIN. These genes were further classified into high CpG content promoters (HCP), intermediate CpG content promoters (ICP), and low CpG content promoters (LCP) based on promoter CpG content (see MATERIALS AND METHODS for classification criteria). For genes with multiple transcripts, 1 transcript was randomly chosen whose accession number is listed in the "Representative Accession #" column for each gene. The expression levels of the 28 genes and fold increase in HG are also shown. HG (data not shown). We then confirmed by RT-QPCR that HG induces IFN-␤ expression (Fig. 3) . Collectively, these results suggest that HG itself can upregulate an antiviral transcription network in monocytes possibly through the induction of IFN-␤.
Basal chromatin profiles of HG up-and downregulated genes. Chromatin is composed of DNA wrapped by an octamer of histones, modified and unmodified, as well as nonhistone proteins including TFs, cofactors, and RNA polymerase complexes. Together, these components define the chromatin state and accessibility, and therefore, mapping their occupancies on genomic DNA is essential to understand of the role of chromatin in gene regulation (42) . To explore the basal chromatin features of genes that were regulated by HG, we profiled 15 selected chromatin modifications using ChIP-promoter arrays containing ϳ24,000 human promoters as described (33, 34) in unstimulated THP1 cells grown in NG. These 15 marks fall into five categories: histone PTMs (histone H3K9Ac, H3K56Ac, H3K4me3, H3K9me2, H3K27me3); histone demethylases (JARD1A, LSD1, JHDM1A, JHDM2A, and JHDM3A), a co-repressor (Sin3A); chromatin remodeling factors (SNF2H and BRG1), and gene transcription machinery (RNA Pol II, RNA Pol II-Ser5P). The rationale is based on the documented role of these marks in gene regulation (9, 54) . Histone H3K4me3, H3K9Ac, and H3K56Ac are associated with promoters and active genes, while H3K9me2 and H3K27me3 are associated with repressed regions and inactive genes (6, 54) . Histone demethylases affect gene regulation by erasing histone modifications (35) . SIN3A is a transcriptional repressor (18), while SNF2H and BRGI are components of ATP-dependent chromatin remodeling complexes (41, 43) . RNA PolII marks transcriptionally active chromatin (16, 19, 54) . As anticipated, the heat map of all RefSeq genes (in the basal unstimulated state) of these chromatin marks around promoter regions (Fig. 4A) shows that histone H3K4me3, H3K9Ac, H3K56Ac, RNA Pol II, and RNA Pol II Ser-5=P marks were generally associated with active genes, while H3K27me3 and H3K9me2 were associated with repressed genes.
We next examined the ChIP-chip data of each chromatin mark at the promoter/enhancer regions of the 337 genes upregulated by HG (Table 1 ) and 326 genes downregulated by HG (Table 2 ) and compared them with that of all RefSeq genes. From the composite profiles of the 15 marks tested (Fig.  4, B-P) , only histone H3K9Ac depicted higher enrichment at the promoter/enhancer regions of HG-upregulated genes relative to all RefSeq genes (Fig. 4E) . Since H3K9Ac levels generally have a positive correlation with gene expression, these data suggest that H3K9Ac might be indispensable for the poised "open" chromatin status required for both basal gene expression and induction by HG. Interestingly, the HG-downregulated gene set also had higher levels of H3K9Ac (Fig. 4E) as well as other active chromatin marks including RNA Pol II (Fig. 4B) , RNA Pol II Ser5P (Fig. 4C), H3K4me3 (Fig. 4D) , and H3K56Ac (Fig. 4F) . The reason for this is not entirely clear, but further examination indicated that most of these HG-downregulated genes are normally highly expressed genes involved in key cellular functions (Fig. 2) and hence would be expected to be enriched in active chromatin modifications.
HG-upregulated genes with LCP are in a poised state with multiple active chromatin marks. We next examined the promoters of the HG-upregulated genes more closely to determine if they had any distinctive chromatin modifications related to their upregulation in response to HG. Increasing evidence shows that promoter CpG islands play a central role in gene regulation, particularly in transcription initiation (12) . Notably, Ͼ60% of human genes have CpG islands located near the TSS, termed HCP, in contrast to LCP. In general, HCP genes tend to have greater enrichment of active chromatin marks and higher expression levels than LCP genes (25) .
To explore the role of promoter CpG islands in HG-induced gene regulation, we compared the basal state profiles of the 15 chromatin marks at the promoters of the 337 HG-upregulated genes between the HCP/ICP and LCP gene sets. Specifically, the ChIP-promoter array datasets of the 15 chromatin modifications at the 337 HG-upregulated genes were extracted and divided into HCP/ICP and LCP genes based on their promoter CpG content as described in MATERIALS AND METHODS. Heat maps of chromatin features were generated based on log2 enrichment ratios of the microarray probes located at the promoter/enhancer regions of the 337 HG-upregulated genes (Fig. 5A) , which showed that HCP/ICP and LCP genes have distinct chromatin patterns of key histone PTMs and other chromatin components. This is more clearly demonstrated in the chromatin composite profiles, which show the average enrichment levels of each mark at HG-upregulated genes with HCP/ICP (solid red line) and LCP (solid blue line) (Fig. 5,  B-P) . Compared with LCP, it is evident that, in the promoter regions of HG-upregulated genes, HCP/ICP had markedly higher enrichment signals of active marks RNA Pol II (Fig.  5B) , RNA Pol II ser-5P (Fig. 5C ), histone H3K4me3 (Fig. 5D) , and H3K56Ac (Fig. 5F ). Slightly higher enrichments of JARID1A (Fig. 5I), LSD1(Fig. 5J), JHDM1A (Fig. 5K) , SIN3A (Fig. 5N) , and SNF2H (Fig. 5O) were also seen, and very little differences in the levels of H3K9me2 (Fig. 5G) , H3K27me3 (Fig. 5H), JHDM2A (Fig. 5L), JHDM3A (Fig.  5M) , and BRG1 (Fig. 5P) . In parallel, we also generated composite profiles of all RefSeq genes with HCP/ICP (Fig. 5 , B-P, dashed red line) and LCP (Fig. 5 , B-P, dashed blue line) for each chromatin mark. For all RefSeq genes, the differences in composite profiles between HCP/ICP and LCP followed a pattern similar to the HG-upregulated genes (Fig. 5 , B-P, dashed red line vs. dashed blue line), with HCP/ICP in general depicting enhanced enrichment of active marks, and lower or no changes in repressive marks like H3K9me2, H3K27me3, JHDM3A, Sin3A, and BRG1.
Although the basal chromatin state of HG-upregulated genes with HCP/ICP was in general very similar to that of all RefSeq HCP/LCP genes (solid vs. dashed red lines), which is in line with the known features of HCP/ICP, it was important to note that the chromatin state of HG-upregulated genes with LCP clearly showed marked differences from that of all RefSeq genes with LCP (solid vs. dashed blue lines). More specifically, we observed that: 1) HG-upregulated genes with LCP depict markedly higher enrichment levels of active marks including RNA Pol II, RNA PolI ser-5P, histone H3K4me3, H3K9Ac, and H3K56Ac compared with all RefSeq genes with LCP (Fig. 5, B-F , solid blue lines vs. dashed blue lines); 2) although the enrichment levels of H3K4me3 (Fig. 5D) and H3K56Ac (Fig. 5F ) at HG-upregulated genes with LCP were lower than those of HG-upregulated genes with HCP/ICP in the upstream regions of TSS, they increased sharply soon after TSS (0 to ϩ500 bp) to reach levels similar to HCP/ICP (Fig. 5 , D and F, solid blue line vs. solid red line); 3) the levels of histone H3K9Ac were very similar at HG-upregulated genes with LCP as well as with HCP/ICP in the entire promoter region (Fig. 5E , solid blue line vs. solid red line). Together, these high-resolution data demonstrate that, overall, HG-upregulated genes with LCP depict greater enrichment levels of active chromatin marks in contrast to the remaining RefSeq genes with LCP where low levels of active chromatin marks were observed as expected. This indicates that an open promoter configuration at LCP genes, similar to HCP/ICP, is necessary for upregulation by HG.
More specifically, we observed that, out of the 28 common genes shared between HGIN and IDIN (Table 5) , 15 were LCP genes. The twofold enrichment of LCP genes within the 28 genes is noteworthy (54% compared with 28% in all RefSeq genes, 2 P Ͻ 0.0018). In fact, all these 15 genes were ISGs with critical antiviral biological functions suggesting that these LCP genes have functionally important roles relative to the remaining HG-induced genes. In addition, as seen in Fig. 6 , their promoter H3K4me3 (active mark) levels were markedly greater than the average levels at RefSeq LCP genes (ϳ0.17, Fig. 6 , last bar). Moreover, we compare the increased expression levels of HG-upregulated genes with HCP/ICP and LCP. The average induction of LCP genes by HG was fourfold compared with 2.5-fold for HCP/LCP genes (Fig. 7) , suggesting, in general, that regulation of LCP genes could be biologically important. Collectively, our data suggest that the promoters of HG-upregulated genes with LCP need to be in a poised and permissive state to be selected for subsequent active transcription and induction by HG. This poised state is enriched in multiple active chromatin marks such as histones H3K4me3, H3K9Ac, H3K56Ac, RNA Pol II ser-5P, and perhaps RNA Pol II. HG-upregulated genes with LCP likely play important roles in the HGIN.
Relevance to primary human monocytes. THP1 cells are widely used to investigate the functions of human monocytes (40) . We next examined whether the results obtained in THP-1 cells can be recapitulated in peripheral blood CD14 ϩ monocytes obtained from normal human volunteers cultured in HG or NG for 72 h. We observed that, among eight candidate genes tested in Fig. 3 , seven were also significantly upregulated by HG in human monocytes (Fig. 8A) . Furthermore, composite files from ChIP-chip data performed with these primary monocytes in NG (Fig. 8B) revealed that the average promoter enrichment levels of H3K4me3 (mark of active gene promoters) was similar to that seen in THP-1 cells (Fig. 5D) , including the marked increases at regions downstream of TSS in LCP HG-upregulated genes compared with all RefSeq genes with LCP (Fig. 8B) . Moreover, the majority of the LCP genes in HGIN exhibited high H3K4me3 levels also in primary monocytes (Fig. 8C) , similar to THP1 cells (Fig. 6) . Overall, these results indicate that the upregulation of antiviral response genes by HG can also occur in primary human peripheral blood monocytes. 26). They also identified the "metabolic memory" phenomenon, which suggests that prior exposure to hyperglycemia due to nonintensive glycemic control can result in persistently increased risk for diabetic complications even long after glucose normalization instituted by intensive glycemic control. Despite major efforts, the mechanisms behind these observations are still not fully clear.
To better understand the effects of hyperglycemia, we adopted the RNA-Seq approach because of its potential to reveal unprecedented insights into the diabetes-induced misregulated transcriptome. Indeed, this led to the discovery of a novel antiviral response network, HGIN, mediated by IRFs in HGtreated monocytes that was not identified in previous studies. ISGs were core components of this network, which, interestingly, depicted marked overlap with the IDIN network implicated in T1D risk (22) . Further evaluation of the basal chromatin features of the HG-upregulated genes revealed that an open chromatin state (premarked with active histone modifications and Pol II) at promoter regions of these genes was a prerequisite for regulation by HG. Importantly, within the HG-upregulated gene set, similar to the HCP genes, the LCP genes were also poised for induction since they were also enriched with active chromatin marks, despite the "general rule" that LCPs have lower active chromatin marks. This clearly demonstrates the importance of chromatin states of promoter regions for gene upregulation by HG in monocytes.
The well-studied type 1 IFN pathway functions as a host defense against pathogens and triggers numerous genes collectively termed the antiviral response program. This occurs through the JAK-STAT1/2 pathway to activate the IRFs (49) . IRFs interact directly with histone acetylase/deacetylases to control the balance of histone PTMs at target genes (3). IRF7 is the master regulator of type 1 IFN-dependent immune responses (23) , which are critical for immunity against viruses.
In this study, we demonstrated that HG has an IFN-␣-like effect, triggering an ISG network likely through IFN-␤, which therefore could be involved in initiating human T1D. The connection between IFN-␣/␤ and T1D is well known including in human and rodent models (4, 50). IFN-␣ initiates T1D through upregulation IFN-␣ target genes in CD4 ϩ cells in nonobese diabetic mice (27) . Moreover, T1D occasionally appears during IFN-␣ therapy for unrelated diseases such as chronic hepatitis C. Interestingly, patients who developed IFN-␣-induced T1D were genetically susceptible to T1D (36, 37) . Our study clearly showed that HG upregulates an ISG network in THP1 cells as well as in human primary monocytes. Although it is well known that HG contributes to diabetic complications through upregulating cytokines such as TNF-␣, IL-1␤, IL-6, and MCP-1 in monocytes (10, 14, 20, 24, 32, 45, 46) , our results reveal the IFN-␣ pathway as another major player in this scenario. Overall, this study has revealed for the first time that HG treatment of monocytes can trigger an IRF-mediated HGIN featured by ISGs, which can be implicated in T1D and its complications. Furthermore, epigenomic profiling uncovered key distinctive chromatin features of the HG-upregulated genes. These results provide novel new insights into the role of HG in the pathology of diabetes and its complications as well as chromatin states in HG-regulated gene expression.
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